Latest Ratios: P/E Ratio 123.8x · EV/EBITDA 32.3x · ROE 2.5%. (2016–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $10.0B | $7.9B | $3.7B | — | — | — | — | — | — | — | — |
| Enterprise Value | $11.5B | $9.3B | $5.5B | — | — | — | — | — | — | — | — |
| P/E Ratio → | 123.81 | 112.05 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 4.43 | 3.47 | 1.79 | — | — | — | — | — | — | — | — |
| P/B Ratio | 2.58 | 2.34 | 1.61 | — | — | — | — | — | — | — | — |
| P/FCF | 60.41 | 47.34 | 44.12 | — | — | — | — | — | — | — | — |
| P/OCF | 34.04 | 26.67 | 21.08 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.13 | 2.66 | — | — | — | — | — | — | — | — |
| EV / EBITDA | 32.35 | 26.24 | 15.36 | — | — | — | — | — | — | — | — |
| EV / EBIT | 68.49 | 69.38 | 58.68 | — | — | — | — | — | — | — | — |
| EV / FCF | — | 56.22 | 65.44 | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 1.8% | 1.8% | 20.1% | 19.2% | 20.8% | 14.4% | 13.4% | 18.0% | 18.3% | 20.2% | 18.4% |
| Operating Margin | 7.4% | 7.4% | 6.6% | 4.1% | 5.6% | 11.0% | 11.1% | 15.5% | 15.8% | 17.1% | 15.5% |
| Net Profit Margin | 3.1% | 3.1% | -1.8% | -3.8% | -5.0% | -3.8% | 0.2% | -0.4% | 1.2% | 1.1% | -14.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.5% | 2.5% | -2.0% | -4.6% | -4.7% | -3.3% | 0.2% | -0.4% | 1.0% | 0.8% | -10.1% |
| ROA | 1.4% | 1.4% | -0.8% | -1.5% | -1.7% | -1.2% | 0.1% | -0.2% | 0.5% | 0.4% | -5.2% |
| ROIC | 2.8% | 2.8% | 2.4% | 1.3% | 1.6% | 2.9% | 3.4% | 5.1% | 5.1% | 5.2% | — |
| ROCE | 3.4% | 3.4% | 4.1% | 2.1% | 2.4% | 4.3% | 4.4% | 6.6% | 6.6% | 6.7% | 5.6% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.47 | 0.47 | 0.81 | 2.07 | 1.72 | 1.37 | 1.75 | 1.67 | 1.16 | 0.91 | 0.82 |
| Debt / EBITDA | 4.47 | 4.47 | 5.22 | 9.61 | 9.73 | 8.55 | 7.11 | 5.60 | 5.27 | 4.28 | 2.81 |
| Net Debt / Equity | — | 0.44 | 0.78 | 2.04 | 1.68 | 1.32 | 1.64 | 1.63 | 1.13 | 0.88 | 0.80 |
| Net Debt / EBITDA | 4.15 | 4.15 | 5.01 | 9.48 | 9.51 | 8.27 | 6.68 | 5.44 | 5.15 | 4.16 | 2.74 |
| Debt / FCF | — | 8.89 | 21.32 | — | 36.30 | — | 19.40 | 72.87 | 35.51 | 14.43 | 16.98 |
| Interest Coverage | 1.57 | 1.57 | 0.73 | 0.53 | 0.31 | 0.07 | 0.46 | 0.99 | 1.25 | 1.08 | -2.63 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | — | 0.37 | 0.20 | 0.61 | 0.30 | 1.83 | 1.91 | 2.09 | 2.18 | 2.51 |
| Quick Ratio | — | — | 0.35 | 0.19 | 0.57 | 0.28 | 1.71 | 1.77 | 1.95 | 2.02 | 2.35 |
| Cash Ratio | — | — | 0.08 | 0.03 | 0.12 | 0.07 | 0.58 | 0.31 | 0.24 | 0.27 | 0.27 |
| Asset Turnover | — | 0.42 | 0.46 | 0.41 | 0.34 | 0.28 | 0.37 | 0.38 | 0.39 | 0.37 | 0.35 |
| Inventory Turnover | — | — | 84.92 | 77.15 | 64.81 | 57.16 | 41.59 | 41.96 | 43.68 | 43.38 | 46.34 |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.9% | 2.1% | 3.3% | — | — | — | — | — | — | — | — |
| Payout Ratio | 234.3% | 234.3% | — | — | — | — | 1248.1% | — | 451.0% | 497.0% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.8% | 0.9% | — | — | — | — | — | — | — | — | — |
| FCF Yield | 1.7% | 2.1% | 2.3% | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 1.9% | 2.1% | 3.3% | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $167M | $131M | $66M | $66M | $66M | $66M | $45M | $50M | $50M | $49M |
Operational labor cost inflation
As reported in recent quarterly filings, AHR's NOI margin experienced a sharp contraction to -1.3% in 2026Q1, deviating significantly from the 20% range maintained throughout 2025, which highlights the inherent sensitivity of the company's integrated senior health campus model to facility-level operating expense fluctuations.
The dramatic swing in NOI margin suggests that the company's RIDEA-style operating structure leaves it vulnerable to sudden spikes in labor and utility costs. Investors should monitor whether this margin compression is a temporary seasonal anomaly or a structural challenge resulting from the high-touch nature of the integrated care platform.
Based on the company's reported financial statements, the FFO payout ratio has fluctuated between 32.8% and 151.5% over the last ten quarters, indicating that dividend sustainability remains tethered to the volatile conversion of operating income into recurring cash flow after accounting for necessary maintenance capital expenditures.
The wide variance in payout ratios suggests that the dividend is not yet supported by a consistent, predictable stream of AFFO. Analysts should exercise caution, as the significant gap between FFO and AFFO implies that substantial capital reinvestment is required to maintain the portfolio's competitive standing.
According to the latest quarterly data, AHR has aggressively reduced its debt-to-equity ratio from a peak of 2.07 in 2023Q4 to 0.00 in 2026Q1, signaling a strategic pivot toward equity-funded growth and a significant strengthening of the corporate balance sheet against interest rate volatility.
This rapid deleveraging appears to be a deliberate effort to improve the company's credit profile following its transition to a public entity. While this shift reduces interest expense risk, investors should investigate whether the current capital structure provides sufficient leverage to drive accretive growth in the competitive healthcare facilities market.
As indicated by the company's financial data, the use of a standard P/E ratio of 121.43 is deeply misleading for AHR, as it fails to account for the massive non-cash depreciation charges inherent in the REIT's property-heavy business model and the consolidation of operating businesses.
The P/E ratio obscures the company's actual cash-generating capacity by treating depreciation as a permanent loss rather than a non-cash accounting entry. Analysts should instead prioritize P/FFO or P/AFFO to better capture the recurring cash flow available to shareholders, as these metrics provide a more accurate reflection of the REIT's operational performance.
Includes 30+ ratios · 10 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AHR stock.
American Healthcare REIT, Inc.'s current P/E ratio is 123.8x. The historical average is 112.0x. This places it at the 100th percentile of its historical range.
American Healthcare REIT, Inc.'s current EV/EBITDA is 32.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.8x.
American Healthcare REIT, Inc.'s return on equity (ROE) is 2.5%. The historical average is -2.1%.
Based on historical data, American Healthcare REIT, Inc. is trading at a P/E of 123.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
American Healthcare REIT, Inc.'s current dividend yield is 1.88% with a payout ratio of 234.3%.
American Healthcare REIT, Inc. has 1.8% gross margin and 7.4% operating margin.
American Healthcare REIT, Inc.'s Debt/EBITDA ratio is 4.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.